Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Total Liabilities (2019 - 2023)

Alx Oncology Holdings' Total Liabilities history spans 5 years, with the latest figure at $51.4 million for Q3 2023.

  • For Q3 2023, Total Liabilities rose 67.14% year-over-year to $51.4 million; the TTM value through Sep 2023 reached $51.4 million, up 67.14%, while the annual FY2022 figure was $43.0 million, 151.11% up from the prior year.
  • Total Liabilities for Q3 2023 was $51.4 million at Alx Oncology Holdings, up from $33.2 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $75.9 million in Q1 2020 and bottomed at $6.2 million in Q4 2020.
  • The 5-year median for Total Liabilities is $24.9 million (2022), against an average of $30.4 million.
  • The largest annual shift saw Total Liabilities tumbled 83.43% in 2020 before it skyrocketed 175.95% in 2021.
  • A 5-year view of Total Liabilities shows it stood at $11.0 million in 2019, then plummeted by 43.31% to $6.2 million in 2020, then surged by 175.95% to $17.1 million in 2021, then skyrocketed by 151.11% to $43.0 million in 2022, then increased by 19.36% to $51.4 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Total Liabilities are $51.4 million (Q3 2023), $33.2 million (Q2 2023), and $37.8 million (Q1 2023).